Biologics Summit Part II Afternoon Session

CRS/IPEC Americas Presents - Biologics Summit Part II: Breakthroughs in Drug Delivery Devices: Facilitating Decentralized Care and Global Biotherapeutic Accessibility - Afternoon Session

The increasing pressures on global healthcare systems, exacerbated by the recent pandemic, underscore the need to enhance drug delivery in decentralized settings. These settings encompass dosing in clinics, physician offices, community centers, as well as at-home and self-administration, thus considering individual preferences and capabilities. A reduction in dosing frequency to limit in-clinic visits is also part of this strategy and is expected to improve access to medications, particularly in countries with limited healthcare infrastructures and rural regions.

Especially for biotherapeutics requiring parenteral administration, dosing regimens are typically complex, requiring close supervision by professional caregivers.

Drug delivery scientists and device engineers play a crucial role in realizing the broad applicability and affordability of novel drug delivery devices. Close collaboration with regulators, payers, healthcare providers, and patients is necessary to co-create customer-centric devices that meet the needs of a broader population.

The symposium will feature experts from the pharmaceutical industry, biotech companies, and academia sharing insights into the latest status of drug delivery devices. Administration routes discussed will include subcutaneous and intravitreal dosing, inhalation devices, as well as oral delivery.

Participants will learn about challenges and opportunities associated with various device types, be introduced to the regulatory framework underlying the approval process, understand user preferences and co-creation approaches, and explore novel clinical development approaches.

Agenda

9:00 am - 9:10 am: Opening Remarks & Overview on Drug Delivery Devices
Simon Matoori, PhD, Université de Montréal Montreal

9:10 am - 9:15 am: The Role of Drug Delivery Devices in Enabling Access through Decentralized Care
Beate Bittner, PhD, F. Hoffmann - La Roche

9:15 am - 9:35 am: Recent Developments with Devices for Intravitreal Injection
Eva Rosenberg, PhD, Roche Diagnostics GmbH

9:35 am - 9:55 am: Implantable Polymeric Systems for Treating Brain Tumors and Osteoarthritis
Annalisa Palange, PhD, Italian Institute of Technology

9:55 am - 10:15 am: High-Volume Subcutaneous Injection Devices - Pushing the Injection Volume Boundaries
David Kang, PhD, Halozyme

10:15 am - 10:35 am: Development and Utilization of a Wearable Injector for High Volume / High Dose Subcutaneous Delivery
Ron J. Pettis, MS, PhD, Becton Dickinson

10:35 am - 10:55 am: The Role of Connected Subcutaneous Devices in Enhancing Access to Treatment
Beate Bittner, PhD, F. Hoffmann - La Roche

10:55 am - 11:15 am: Break

11:15 am - 12:00 pm: Oral Expedition: Charting New Territories in Gastrointestinal Drug Delivery for Challenging Therapeutics
Giovanni Traverso, MB, BChir, PhD, MIT, Harvard Medical School

12:00 pm - 1:00 pm: Lunch Break

1:00 pm - 1:15 pm: Wrap up for Biologics Summit Part I
Nigel Langley, PhD, MBA, FRSC, Gaylord Chemical Company

1:15 pm - 1:25 pm: Skin and Mucosa Focus Group Industry Sub-Team

1:25 pm - 1:45 pm: Regulatory aspects of device development
Paola Minghetti, PharmD, PhD, University of Milan

1:45 pm - 2:15 pm: Panel discussion with all Speakers
Moderator: Simon Matoori, PhD, Université de Montréal Montreal

2:15 pm - 2:20 pm: Closing Remarks
Simon Matoori, PhD, Université de Montréal Montreal & Beate Bittner, PhD, F. Hoffmann - La Roche